Skip to main content

Table 1 WHO trial registration data set

From: Randomised controlled trial of analgesia for the management of acute severe pain from traumatic injury: study protocol for the paramedic analgesia comparing ketamine and morphine in trauma (PACKMaN)

Data Category

Information

Primary registry and trial identifying number

ISRCTN14124474

Date of registration in primary registry

22/10/2020

Secondary identifying numbers

EudraCT number: 2020-000154-10

IRAS ID: 1003404

CPMS ID: 46938

REC reference: 20/WS/0126

Source of monetary or material support

National Institute for Health Research (NIHR)

Primary sponsor

University of Warwick

Secondary sponsor

N/A

Contact for public queries

packman@warwick.ac.uk

Contact for scientific queries

m.a.smyth@warwick.ac.uk

Public title

PACKMaN

Scientific title

Paramedic Analgesia Comparing Ketamine and MorphiNe in trauma: PACKMaN

Countries of recruitment

UK

Health condition or problem studied

Acute severe pain from traumatic injury in adults

Interventions

Control: Pre-hospital morphine sulphate (0.10 mg/kg) Intervention: Pre-hopsital ketamine hydrochloride (0.15 mg/kg)

Key inclusion and exclusion criteria

Inclusion:

Age ≥ 16

Patient reports a pain score ≥ 7/10 on a 0–10 numeric rating scale following acute traumatic injury

Intravenous (IV) or intraosseous (IO) access obtained

Determined by a paramedic to require IV morphine or equivalent

Exclusion:

Known or suspected pregnancy

Unable to articulate severity of pain using the 0–10 numeric rating scale

 

Lack of capacity due to a reason other than pain

IV/IO ketamine or opioid analgesia immediately prior to randomisation

Known contraindication to ketamine or morphine as per the SmPC

Patient declines participation

Known prisoner

 

Study type

Interventional, blinded, randomised, individual assignment. Phase III trial

Date of first enrolment

10-Nov-21

Target sample size

446

Current recruitment

362

Recruitment status

Recruiting

Primary outcome

Outcome name: Sum of pain intensity difference score

Metric/method of measurement: using a 0–10 numerical rating scale

Timepoint: From randomisation to arrival at hospital

Key secondary outcomes

Effectiveness of pain relief and overall patient experience from randomisation to arrival at hospital

Incidence of side effects and adverse events

Resource use

Longer term outcomes

Ethics Review

Status: Approved

Date of Approval: 01/09/2020

Committee: West of Scotland Research Ethics Committee

Contact: wosrec1@ggc.scot.nhs.uk